Cargando…
Identification of Serotonin as a Predictive Marker for Breast Cancer Patients
PURPOSE: Cumulative evidence has demonstrated that breast cancer was the most commonly diagnosed cancer in women. Despite growing evidence for a link between serotonin and tumorigenesis, research on the expression of serotoninergic systems in the human breast cancer cell and tissue has only rarely b...
Autores principales: | Xie, Qing-E, Du, Xin, Wang, Mengyao, Xie, Fenfen, Zhang, Zuoyang, Cao, Yunxia, Liu, Yajing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144847/ https://www.ncbi.nlm.nih.gov/pubmed/34045888 http://dx.doi.org/10.2147/IJGM.S310591 |
Ejemplares similares
-
ASMT Regulates Tumor Metastasis Through the Circadian Clock System in Triple-Negative Breast Cancer
por: Xie, FenFen, et al.
Publicado: (2020) -
Serotonin biosynthesis as a predictive marker of serotonin pharmacodynamics and disease-induced dysregulation
por: Welford, Richard W. D., et al.
Publicado: (2016) -
Serotonin, neural markers, and memory
por: Meneses, Alfredo
Publicado: (2015) -
Identification and Pharmacological Characterization of Two Serotonin Type 7 Receptor Isoforms from Mythimna separata
por: Chen, Wenbo, et al.
Publicado: (2022) -
Identification of FOXM1 as a specific marker for triple-negative breast cancer
por: Tan, Yanli, et al.
Publicado: (2018)